GMP Data Integrity Best Practices and Regulatory Expectations for the Pharmaceutical Industry Including a Review of the New 2018 MHRA Data Integrity Definitions & Guidances and the FDA’s Most Recent Draft Guidance

Live, Interactive Training Webinar

Date: Thursday December 13, 2018
Time: 9:30am - 11:30am ET (New York Time)
Instructor: Peter Calcott Ph.D. Biography>>>

Member Registration ►

Registration Form ►

Data integrity is the cornerstone of your operations and the trusting relationship you have with your customers – the agencies and patients. This is true in the development cycle and submissions as well as in the manufacturing phases of the product lifecycle. Lapses in data integrity can hit any corporation and can be as simple as miscalculations all the way to fabrication of data, unintentional to intentional. Are you vulnerable? And do you really know if you are? Some serious failures have plagued manufacturers with FDA issuing warning letters. The Europeans have also detected the same data integrity issues as well and reported on them. Now guidances have been issued from these agencies on the topic to advise us. In 2015, MHRA issued a comprehensive Guidance on the topic followed by another in 2016 to broaden the topic. In 2018, MHRA finally issued the full complete Guidance. Recently in April 2016, FDA has also issued their own a guidance to help us. In addition, the WHO and PIC/S have also issued guidances in 2016.

In this live interactive webinar we will examine the issues surrounding data integrity lapses. We will examine the types, how to detect them, how to determine the root causes of these failures. Intentional and unintentional failures point to different root causes which then lead to different solutions. We will examine how the Europeans have taken the issue seriously and are meeting the challenge face on by reviewing the new MHRA GMP Data Integrity Definitions and Guidance released in January 2015. The FDA approach has been less direct but still forceful with them issuing a Guidance in early 2016. The MHRA broadened the topic with their 2018 Guidance to include GXP. The tools described will aid you in detecting, measuring, investigating and remedying the failures leading you to regaining the trust of your customers.

Learning Benefits:
-MHRA GMP data integrity definitions and guidances are explained.
-FDA data integrity guidance definitions and principles are described.
-How to examine your supply chain and development programs with the use of Quality Risk Management to identify where risk of data integrity lapses are present.
- The tell-tale signs that you have data integrity problems.
-To tell the difference between intentional and unintentional failures of data integrity.
-How to develop a remediation plan to decrease risk to an acceptable level in your operations.
-How to be proactive in areas the FDA focused on and by learning from the Europeans and being ahead of the game.
-How regulatory agencies detect data integrity problems.
- Understanding how MHRA vs the FDA are tackling the issues
How to integrate the FDA and MHRA approaches into your data integrity program

Regulations that will be Covered:
Each country has its own specific sets of regulations. Below are citations from ICH and examples of regulations that are applicable to data integrity process and philosophy:
- EMEA Eudralex Volumes 1, 2, 3, 4, 9 for Drugs and Biologics in EU.
- Code of Federal Regulations 21 sections 210, 211 for Biological products and Drugs and 600 series for Biologicals in addition for USA
- MHRA GMP Data Integrity Definitions and Guidance for Industry released in March 2015
- MHRA GXP data integrity guidance of 2018
- FDA Data Integrity and Compliance With CGMP Guidance released in April 2016
- EMA data integrity guidance 2016
- WHO data integrity guidance 2016
- PIC/S data integrity guidance 2016
- International Conference on Harmonisation Quality Series with an emphasis on ICH Q9.

Webinar outline and time breakdown:

Time*
09:15 AM Log In Period
09:30 AM Introduction
09:40 AM What is data integrity?,
The impact of data integrity issues,
Where can data integrity failures happen?,
How to know when it happens,
Intentional and unintentional types of failure,
10:30 AM Break
10:40 AM How to get to the root cause of data integrity failures,
The long slow route to repairing the damage of failures,
What the EU is saying via the MHRA guidance
FDA approach to data integrity problems,
Warning letters tell you how it is detected by the FDA,
How to prevent data integrity failures from happening,
Conclusions,
11:30 AM Live Questions & Discussion

*Please note all times are Eastern Time (New York Time)


This live training webinar includes the following for each registered attendee:

  • A copy of the presentation slides
  • A certificate of participation for attendee training records

Who should attend:
The following individuals or disciplines will benefit from attending this Webinar:

  • Senior management
  • Quality Assurance personnel and management
  • Quality Control personnel and management
  • Compliance auditors and management
  • Process development scientists and management
  • Supply Chain and Logistics managers
  • Regulatory Affairs Professionals
  • Engineering staff and management
  • IT management and staff working in regulated areas

Registration Form ►


Instructor: Peter Calcott Ph.D.

Peter H. Calcott, Ph.D. is President, Calcott Consulting which is focused on delivering solutions to pharmaceutical and biotechnology companies in the areas of corporate strategy, supply chain, quality, clinical development, regulatory affairs, corporate compliance and enterprise e-solutions. He is also an Academic Program Developer for the University of California, Berkeley’s Biotechnology and Pharmaceutics Postgraduate Programs. Prior to this he was VP at the executive team level at PDL BioPharma where he was responsible for development and implementation of Quality & Compliance strategy across the corporation… Full Bio>>>

 

 

System Requirements:

All Pharma Webinars live training programs audio and visual are delivered via Cisco WebEx with basic system requirements of a computer with internet access and a telephone to access the audio portion of the presentations. You can choose to access the audio through your computer.

Live Training Benefits:

• Pharma Webinars training webinars and programs are presented exclusively as live events only.

• Designed and delivered based on e-learning best practices, Pharma Webinars' live training webinars and programs are as effective as in person training.

• Live training webinars and multi-part training programs are strictly educational based, and do not promote or endorse any products or services whatsoever.

• An interactive live Q&A and discussion period is included in each live training presentation. Questions can also be submitted to the speaker via email both prior to and following the live training webinar as a means of improving participant experience, and ensuring successful topic comprehension.

• Live presentations ensure that all live training webinars and programs are engaging and informative, allowing trainees to exchange ideas through audio conferencing and live chat during each presentation in real time. Each live training session includes a dedicated live Q&A period allowing trainees to interact directly with the instructor, with quick feedback providing them with concrete understanding of the answers and the training subject itself.

• Each Pharma Webinars live training webinar and program content is updated on regular basis to provide the latest regulatory, operational and technological trends in the international pharmaceutical arena. As regulatory expectations, guidance, or industry trends change, so does our training in order to reflect those changes as soon as the changes are released.

• Pharma Webinars' instructors are the most recognized subject matter experts in the industry who are selected based on very strict qualification criteria. They are coached on the latest e-learning speaking methods in order to make each presentation engaging, memorable and very effective.

• Each registered attendee receives an exact copy of the presentation slides and other course handouts significantly reducing the learning curve as trainees can refer back to this material in the future.

• All trainees receive a Certificate of Attendance for each live training webinar and program they attend to be kept for training records.


Client Testimonials:

"The live webinar was very useful to our team, the content was relevant and the instructor was very knowledgeable" QC Microbiology Supervisor, NJ

"We were very satisfied with the live presentation; we appreciated the speaker staying on to answer all of our questions" QA Director, MA

"Our group enjoyed the live presentation and found the experience much more engaging and worthwhile than any recorded webcasts" Sr Training Manager, CA

"This was my first live training, I found it easy to connect, participate and very useful" Laboratory Analyst, PA

"We had our entire department attend this training program and found it to be very useful, I am very satisfied with the speaker's ability to keep the audience engaged" QC Manager, NY

"Given how recent the content of the webinar was, our team members were very happy with the relevance of the training" VP Clinical Operations, CA

"Is my first time to attend training, I enjoy it very much" Sr Manager, Korea

"Our department found the level of interactivity between the audience and the instructor far beyond that of any other online training that we have attended before. Well done" Director Regulatory Affairs, ON

"Our interest group was spread out over three locations and we were able to participate simultaneously and interact very easily" Lead Compliance Manager, IL

"Well satisfied with the presentation. Our team found the speaker's level of knowledge and his ability to translate that knowledge to our processes very valuable" VP Quality Operations, NC

"We were impressed with the quality of the presentation, and despite our being located in Europe we were able to participate without a hitch" QC Manager, Ireland